The authors reply

New England Journal of Medicine

Volumn 364, Issue 19, 2011, Pages 1879-

  Neu, Josef ^a   Walker, W Allan ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BRAIN HEMORRHAGE; CAUSE OF DEATH; CHILD HEALTH CARE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; EXTREMELY LOW BIRTH WEIGHT; HUMAN; LETTER; MEDICAL LITERATURE; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RESUSCITATION; TREATMENT WITHDRAWAL;

EID: 79955919181     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1102867     Document Type: Letter

References (5)

1. Deshpande G, Rao S, Patole S, Bulsara M. Updated metaanalysis of orobiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921-30.
2. Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J. Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 2010;125:1068-70.
3. Soll RF. Probiotics: are we ready for routine use? Pediatrics 2010;125:1071-2.
4. Neu J. Routine probiotics for premature infants: let's be careful! J Pediatr 2011;158:672-4.
5. Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 2011;93:81-6.